Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Huizinga

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Targeted therapies in rheumatoid arthritis: Focus on rituximabY K Teng, T W Huizinga, J M van Laar
Biochemical Pharmacology|August 15, 1997
The effect of pentoxifylline on human neutrophil migration: a possible role for cyclic nucleotidesJ G Elferink, T W Huizinga, B M de Koster
Annals of the Rheumatic Diseases|January 13, 2001
UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trialM C Polderman, T W Huizinga, S Le Cessie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cellsB A Vance, T W Huizinga, K Wardwell, et al.
Human Genetics|June 1, 1996
Allele-specific quantification of TNFA transcripts in rheumatoid arthritisB M Brinkman, T W Huizinga, F C Breedveld, et al.
Blood|May 1, 1991
Induction of neutrophil FC-gamma receptor I expression can be used as a marker for biologic activity of recombinant interferon-gamma in vivoT W Huizinga, C E Van der Schoot, D Roos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody productionBi-Sheng Liu, Jeroen N Stoop, Tom W Huizinga, et al.
The Journal of Rheumatology|October 24, 2001
Delayed referral of female patients with rheumatoid arthritisL R Lard, T W Huizinga, J M Hazes, et al.
Transfusion|May 1, 1996
HLA class I-eluted platelets as an alternative to HLA-matched plateletsV M Novotny, T W Huizinga, R van Doorn, et al.
Drugs|January 27, 2016
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesCésar Magro-Checa, Elisabeth J Zirkzee, Tom W Huizinga, et al.
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
Biologics : Targets & Therapy|August 27, 2009
Targeted therapies in rheumatoid arthritis: Focus on rituximabY K Teng, T W Huizinga, J M van Laar
Biochemical Pharmacology|August 15, 1997
The effect of pentoxifylline on human neutrophil migration: a possible role for cyclic nucleotidesJ G Elferink, T W Huizinga, B M de Koster
Annals of the Rheumatic Diseases|January 13, 2001
UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trialM C Polderman, T W Huizinga, S Le Cessie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cellsB A Vance, T W Huizinga, K Wardwell, et al.
Human Genetics|June 1, 1996
Allele-specific quantification of TNFA transcripts in rheumatoid arthritisB M Brinkman, T W Huizinga, F C Breedveld, et al.
Blood|May 1, 1991
Induction of neutrophil FC-gamma receptor I expression can be used as a marker for biologic activity of recombinant interferon-gamma in vivoT W Huizinga, C E Van der Schoot, D Roos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody productionBi-Sheng Liu, Jeroen N Stoop, Tom W Huizinga, et al.
The Journal of Rheumatology|October 24, 2001
Delayed referral of female patients with rheumatoid arthritisL R Lard, T W Huizinga, J M Hazes, et al.
Transfusion|May 1, 1996
HLA class I-eluted platelets as an alternative to HLA-matched plateletsV M Novotny, T W Huizinga, R van Doorn, et al.
Drugs|January 27, 2016
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesCésar Magro-Checa, Elisabeth J Zirkzee, Tom W Huizinga, et al.
Pageof 16